Indication
Status asthmaticus
Status asthmaticus is an acute, life-threatening exacerbation of asthma characterized by severe bronchospasm and progressive airflow obstruction that is refractory to initial standard bronchodilator and corticosteroid therapy. Read more about Status asthmaticus
98 drugs 53 manufacturers
Drugs that treat it
Common Status asthmaticus therapies.
SOLU-CORTEF ACT-O-VIAL (PF) (hydrocortisone sodium succinate/PF)
TRIAMCINOLONE ACETONIDE
METHYLPREDNISOLONE ACETATE
METHYLPREDNISOLONE ACETATE
DEPO-MEDROL (methylprednisolone acetate)
KENALOG-40 (triamcinolone acetonide)
METHYLPREDNISOLONE ACETATE
SOLU-MEDROL (methylprednisolone sodium succinate/PF)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonStatus asthmaticus is an acute, life-threatening exacerbation of asthma characterized by severe bronchospasm and progressive airflow obstruction that is refractory to initial standard bronchodilator and corticosteroid therapy.
It primarily affects pediatric and adult patients with preexisting bronchial asthma, involving widespread lower airway inflammation, excessive mucus plugging, and airway hyperresponsiveness.
Pathophysiologically, severe ventilation-perfusion mismatch leads to marked work of breathing, dynamic pulmonary hyperinflation, hypoxemia, and carbon dioxide retention, which can rapidly progress to respiratory muscle fatigue, acute hypercapnic respiratory failure, and cardiac arrest.
- nih.gov
Status asthmaticus is an acute, life-threatening exacerbation of asthma characterized by severe bronchospasm and progressive airflow obstruction that is refractory to initial standard bronchodilator and corticosteroid therapy
- nih.gov
It primarily affects pediatric and adult patients with preexisting bronchial asthma, involving widespread lower airway inflammation, excessive mucus plugging, and airway hyperresponsiveness Pathophysiologically, severe ventilation-perfusion mismatch leads to marked work of breathing, dynamic pulmonary hyperinflation, hypoxemia, and carbon dioxide retention, which can rapidly progress to respiratory muscle fatigue, acute hypercapnic respiratory failure, and cardiac arrest
- nih.gov
It primarily affects pediatric and adult patients with preexisting bronchial asthma, involving widespread lower airway inflammation, excessive mucus plugging, and airway hyperresponsiveness
- nurseslabs.com
Pathophysiologically, severe ventilation-perfusion mismatch leads to marked work of breathing, dynamic pulmonary hyperinflation, hypoxemia, and carbon dioxide retention, which can rapidly progress to respiratory muscle fatigue, acute hypercapnic respiratory failure, and cardiac arrest
- childrensmercy.org
Pathophysiologically, severe ventilation-perfusion mismatch leads to marked work of breathing, dynamic pulmonary hyperinflation, hypoxemia, and carbon dioxide retention, which can rapidly progress to respiratory muscle fatigue, acute hypercapnic respiratory failure, and cardiac arrest
Personalize your experience
Follow Status asthmaticus and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.